CHEN Yingzi, MENG Xinlong, DU Peng, MIU Congqing, FAN Aijuan, LIU Jingjing, LU Dechuan. Effect observation of insulin pump combined with dipeptidyl peptidase-Ⅳ inhibitor on the treatment of newly diagnosed type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2019, 23(8): 22-24. DOI: 10.7619/jcmp.201908005
Citation: CHEN Yingzi, MENG Xinlong, DU Peng, MIU Congqing, FAN Aijuan, LIU Jingjing, LU Dechuan. Effect observation of insulin pump combined with dipeptidyl peptidase-Ⅳ inhibitor on the treatment of newly diagnosed type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2019, 23(8): 22-24. DOI: 10.7619/jcmp.201908005

Effect observation of insulin pump combined with dipeptidyl peptidase-Ⅳ inhibitor on the treatment of newly diagnosed type 2 diabetes mellitus

More Information
  • Received Date: January 08, 2019
  • Accepted Date: February 07, 2019
  • Available Online: December 03, 2020
  • Published Date: April 27, 2019
  •   Objective  To investigate the effect of insulin pump combined with dipeptidyl peptidase-Ⅳ (DPP-Ⅳ) inhibitor on the treatment of newly diagnosed type 2 diabetes mellitus (T2DM).
      Methods  Totally 51 newly diagnosed patients with T2DM were randomly divided into experimental group (insulin pump combined with DPP-Ⅳ inhibitor) and control group (insulin pump alone). After 15 days of treatment, the clinical effect was compared between two groups.
      Results  After treatment, the blood sugar related indexes in both groups significantly improved (P < 0.05), and the blood sugar control of the experimental group was significantly better than that of the control group (P < 0.05). The pancreatic β cell function index, area under curve of C-peptide and insulin resistance index in the experimental group were significantly better than those in the control group (P < 0.05). The dosage of insulin, the ratio of patients with blood sugar reaching the standard completely, the time of blood sugar reaching the standard and the increase value of body mass in the experimental group were significantly better than those in the control group (P < 0.01). The incidence rate of hypoglycemia was 8.00% (2/26) in the experimental group and 12.00% (3/25) in the control group, and there was no significant difference between the two groups (P>0.05). During the treatment, no severe hypoglycemic events and liver and kidney function damage occurred in both groups.
      Conclusion  Insulin pump combined with DPP-Ⅳ inhibitor is effective in the treatment of newly diagnosed T2DM, which can effectively control blood sugar, reduce insulin resistance and weight gain.
  • [1]
    陈灏珠. 内科学[M]. 8版. 北京: 人民卫生出版社, 2013: 1-54.
    [2]
    王凯军, 梅询. 高胰岛素血症与动脉粥样硬化研究现状[J]. 实用临床医学, 2014, 9(10): 129-130. https://www.cnki.com.cn/Article/CJFDTOTAL-KDYZ201301015.htm
    [3]
    邢莉, 申虎威. 地特胰岛素加三餐前速效胰岛素与胰岛素泵短期强化治疗对2型糖尿病的疗效比较[J]. 中国糖尿病杂志, 2012, 20(2): 126-128. doi: 10.3969/j.issn.1006-6187.2012.02.012
    [4]
    Ismail-Beigi F. Pathogenesis and glycemic management of type 2 diabetes mellitus: a physiological approach[J]. Arch Iran Med, 2012, 15(4): 239-246. http://www.ncbi.nlm.nih.gov/pubmed/22424044
    [5]
    谢艳红, 莫朝晖, 金萍, 等. 初诊2型糖尿病短期胰岛素强化治疗后胰岛β细胞功能的动态变化[J]. 中国糖尿病杂志, 2008, 16(4): 225-227. doi: 10.3321/j.issn:1006-6187.2008.04.010
    [6]
    陆浩, 钱菊英, 葛均波. 高胰岛素血症与型糖动脉粥样硬化[J]. 中国临床医学, 2008, 15(1): 35-38. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYX200801013.htm
    [7]
    Müller W A, Faloona G R, Aguilar-Parada E, et al. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion[J]. N Engl J Med, 1970, 283(3): 109-115. doi: 10.1056/NEJM197007162830301
    [8]
    Wajchenberg B L. beta-cell failure in diabetes and preservation by clinical treatment[J]. Endocr Rev, 2007, 28(2): 187-218. http://www.ncbi.nlm.nih.gov/pubmed/17353295
    [9]
    占美, 徐班, 吴逢波. 沙格列汀治疗2型糖尿病的Meta分析[J]. 中国循证医学杂志, 2012, 12(6): 708-710. doi: 10.3969/j.issn.1672-2531.2012.06.016
  • Related Articles

    [1]LI Hongli, YAN Huili. Relationships of glucose metabolism with sex hormones and endometrial receptivity in patients with polycystic ovary syndrome at childbearing age[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 106-111. DOI: 10.7619/jcmp.20233856
    [2]ZHOU Lina, HAN Yanhua, GENG Tiantian, LIU Li. Research progress in effects of hyperandrogenin and insulin resistance on placental pathology of polycystic ovary syndrome
    [J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 137-141. DOI: 10.7619/jcmp.20223478
    [3]DONG Yaguang, ZHU Lin, CHEN Haoyang. Research progress of complications of polycystic ovary syndrome in obstetric department and mechanisms[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 112-116. DOI: 10.7619/jcmp.20214639
    [4]CHEN Haixia, LI Jian, WU Fengyun, BAI Yueran, GU Bei, SONG Xiaohong, SUN Yu, CUI Guangxia, WANG Zijun, WANG Xiaoxue, YIN Cong, YANG Mukun, FAN Li, BAI Wenpei, JIANG Bo. Clinical pathway of ketogenic diet in the treatment of patients with polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 5-7,32. DOI: 10.7619/jcmp.20210722
    [5]JIA Xiaolin, LI Na. Clinical efficiency of laparoscopic ovarian perforation combined with clomiphene citrate and human chorionic gonadotropin in treating infertility induced by polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 102-105. DOI: 10.7619/jcmp.201907027
    [6]BAI Liran, LI Jian, NIU Litian, WANG Aili, WU Fengyun, BAI Wenpei, JIANG Bo. Preliminary report of a single-center clinical study for ketogenic diet intervention of polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 2-5. DOI: 10.7619/jcmp.201907002
    [7]BAO Xudong, XU Yang, FU Rong. Effect of ethinylestradiol and cyproterone acetate tablets combined with metformin on hormone levels of patients with sterility caused by polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2018, (1): 104-106,110. DOI: 10.7619/jcmp.201801032
    [8]MAYILA · Maimaiti, ZULIPIYA · Yiming. Clinical effect of clomiphene combined with human chorionic gonadotropin on ovulation induction in infertility patients with polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2017, (17). DOI: 10.7619/jcmp.201717021
    [9]YIN Jiayao, YANG Ying. Study on modified ultra-long protocol in improving endometrial receptivity in infertile patients with polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2016, (23): 75-77,81. DOI: 10.7619/jcmp.201623022
    [10]CAI Xiuli, YAO Jinyan, ZHANG Yijiao. Effect of Diane-35 combined with clomiphene on treatment of infertility caused by polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2016, (15): 60-62. DOI: 10.7619/jcmp.201615017
  • Cited by

    Periodical cited type(14)

    1. 季晓丽,卢莹莹,赵小瑞. 酶联免疫法和金标法对HIV抗体的检测结果比较. 临床医学工程. 2024(03): 337-338 .
    2. 吴瑕. 化学发光免疫分析法与酶联免疫法检测艾滋病抗体的效果研究. 黑龙江中医药. 2023(02): 362-364 .
    3. 张婷婷. 溶血标本对化学发光免疫分析法检测HIV抗体检验结果的影响. 中国现代医生. 2022(08): 107-110 .
    4. 张缤月. 酶联免疫吸附法和实时荧光定量PCR法检验EB病毒的效果比较. 中国实验诊断学. 2022(07): 1078-1081 .
    5. 马伟刚. 溶血标本在应用化学发光免疫分析法检测HIV抗体时对检测结果的影响. 临床研究. 2022(09): 125-128 .
    6. 万琴. 不同免疫检验法抗HIV检测结果对比. 基层医学论坛. 2022(26): 55-57 .
    7. 江洋. 临床检验中化学发光免疫分析的应用效果分析. 中国实用医药. 2022(21): 87-89 .
    8. 王旭. 分析电化学发光免疫法与酶联免疫吸附试验法检测人类免疫缺陷病毒的临床效果. 中国实用医药. 2021(04): 46-48 .
    9. 刘凤. 艾滋病病毒感染实验检测方法研究进展. 应用预防医学. 2021(02): 185-188+193 .
    10. 张晨磊. 化学发光免疫分析法的研究进展. 医疗装备. 2021(14): 191-192 .
    11. 蔡贤惠. 电化学发光免疫分析与酶联免疫吸附试验检测甲型肝炎病毒Ig M抗体的对比评价. 中国医药指南. 2021(23): 74-75 .
    12. 武红斌. 不同酶免检测试剂检测抗HIV的结果比较. 临床医学研究与实践. 2020(24): 113-115 .
    13. 赵鸿翔. 人类免疫缺陷病毒抗体采用酶联免疫吸附法及电化学发光免疫分析法检测的效果. 中国医疗器械信息. 2020(24): 85-86 .
    14. 严建明,何宝贤,刘玉华. 酶联免疫法筛查HIV抗体应用于诊断艾滋病价值观察. 实用妇科内分泌电子杂志. 2020(18): 156+158 .

    Other cited types(2)

Catalog

    Article views (293) PDF downloads (6) Cited by(16)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return